Evaluation of the effect of two doses of melatonin on sedation and pain control during the cataract surgery

Evaluation of the effect of 3,5 mgr doses of sublingual melatonin on sedation and pain control during the cataract surgery under sedation and local anesthesia

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20160307026950N65

Enrollment

Registered

2024-12-17

Start date

2025-01-09

Completion date

Unknown

Last updated

2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract. Age-related cataract

Interventions

Intervention 1: Intervention group: group 1 In this group, patientsreceive a sublingual tablet containing 3 mg ofMelatonin manufactured by Norm Life 1 hourbefore surgery. After being placed on thesurg

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Over 18 years old Candidate for cataract surgery Informed consent

Exclusion criteria

Exclusion criteria: Mental illnesses Deafness Diabetes Allergies Obesity

Design outcomes

Primary

Measure	Time frame
Intensity of pain. Timepoint: before the intervention, before the operation,after anesthesia and then every 10 minutes untilthe end of recovery. Method of measurement: Behavioral Pain Scale questionnaire.	—

Secondary

Measure	Time frame
Heart rate. Timepoint: Before the intervention, before the operation, after anesthesia and then every 10 minutes until the end of recovery. Method of measurement: ECG monitoring.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactBehzad Nazemroaya

Esfahan University of Medical Sciences

behzad_nazem@med.mui.ac.ir+98 31 3822 2532

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026